INTERLEUKIN-2-FC FUSION PROTEINS AND METHODS OF USE

INTERLEUKIN-2-FC FUSION PROTEINS AND METHODS OF USE

Provided are serum half-life extended-IL-2 variant (IL-2v) heterodimers having reduced binding to the IL2Rα (CD25) subunit. In particular, Fc-IL-2v heterodimers are provided and methods for making and using, e.g. for enhancing an immune response,

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PAPALIA, Giuseppe, BACA, Manuel, GILMORE, Sarah A, MUKHERJEE, Prasenjit K, TAM, Danny W, JAVANBAKHT, Hassan, HUNG, Magdeleine S, KHAN, Shahzada, THOMAS, Majlinda K, KANWAR, Manu, NAGEL, Mark R
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PAPALIA, Giuseppe
BACA, Manuel
GILMORE, Sarah A
MUKHERJEE, Prasenjit K
TAM, Danny W
JAVANBAKHT, Hassan
HUNG, Magdeleine S
KHAN, Shahzada
THOMAS, Majlinda K
KANWAR, Manu
NAGEL, Mark R
description Provided are serum half-life extended-IL-2 variant (IL-2v) heterodimers having reduced binding to the IL2Rα (CD25) subunit. In particular, Fc-IL-2v heterodimers are provided and methods for making and using, e.g. for enhancing an immune response,
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2021365129A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2021365129A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2021365129A13</originalsourceid><addsrcrecordid>eNrjZDD29AtxDfJxDfX29NM10nVzVnALDfb091MICPIPcfX0C1Zw9HNR8HUN8fB3CVbwd1MIDXblYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxjqFGBkaGxmamhkaWjobGxKkCACdFJ7g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INTERLEUKIN-2-FC FUSION PROTEINS AND METHODS OF USE</title><source>esp@cenet</source><creator>PAPALIA, Giuseppe ; BACA, Manuel ; GILMORE, Sarah A ; MUKHERJEE, Prasenjit K ; TAM, Danny W ; JAVANBAKHT, Hassan ; HUNG, Magdeleine S ; KHAN, Shahzada ; THOMAS, Majlinda K ; KANWAR, Manu ; NAGEL, Mark R</creator><creatorcontrib>PAPALIA, Giuseppe ; BACA, Manuel ; GILMORE, Sarah A ; MUKHERJEE, Prasenjit K ; TAM, Danny W ; JAVANBAKHT, Hassan ; HUNG, Magdeleine S ; KHAN, Shahzada ; THOMAS, Majlinda K ; KANWAR, Manu ; NAGEL, Mark R</creatorcontrib><description>Provided are serum half-life extended-IL-2 variant (IL-2v) heterodimers having reduced binding to the IL2Rα (CD25) subunit. In particular, Fc-IL-2v heterodimers are provided and methods for making and using, e.g. for enhancing an immune response,</description><language>eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230601&amp;DB=EPODOC&amp;CC=AU&amp;NR=2021365129A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230601&amp;DB=EPODOC&amp;CC=AU&amp;NR=2021365129A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PAPALIA, Giuseppe</creatorcontrib><creatorcontrib>BACA, Manuel</creatorcontrib><creatorcontrib>GILMORE, Sarah A</creatorcontrib><creatorcontrib>MUKHERJEE, Prasenjit K</creatorcontrib><creatorcontrib>TAM, Danny W</creatorcontrib><creatorcontrib>JAVANBAKHT, Hassan</creatorcontrib><creatorcontrib>HUNG, Magdeleine S</creatorcontrib><creatorcontrib>KHAN, Shahzada</creatorcontrib><creatorcontrib>THOMAS, Majlinda K</creatorcontrib><creatorcontrib>KANWAR, Manu</creatorcontrib><creatorcontrib>NAGEL, Mark R</creatorcontrib><title>INTERLEUKIN-2-FC FUSION PROTEINS AND METHODS OF USE</title><description>Provided are serum half-life extended-IL-2 variant (IL-2v) heterodimers having reduced binding to the IL2Rα (CD25) subunit. In particular, Fc-IL-2v heterodimers are provided and methods for making and using, e.g. for enhancing an immune response,</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDD29AtxDfJxDfX29NM10nVzVnALDfb091MICPIPcfX0C1Zw9HNR8HUN8fB3CVbwd1MIDXblYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxjqFGBkaGxmamhkaWjobGxKkCACdFJ7g</recordid><startdate>20230601</startdate><enddate>20230601</enddate><creator>PAPALIA, Giuseppe</creator><creator>BACA, Manuel</creator><creator>GILMORE, Sarah A</creator><creator>MUKHERJEE, Prasenjit K</creator><creator>TAM, Danny W</creator><creator>JAVANBAKHT, Hassan</creator><creator>HUNG, Magdeleine S</creator><creator>KHAN, Shahzada</creator><creator>THOMAS, Majlinda K</creator><creator>KANWAR, Manu</creator><creator>NAGEL, Mark R</creator><scope>EVB</scope></search><sort><creationdate>20230601</creationdate><title>INTERLEUKIN-2-FC FUSION PROTEINS AND METHODS OF USE</title><author>PAPALIA, Giuseppe ; BACA, Manuel ; GILMORE, Sarah A ; MUKHERJEE, Prasenjit K ; TAM, Danny W ; JAVANBAKHT, Hassan ; HUNG, Magdeleine S ; KHAN, Shahzada ; THOMAS, Majlinda K ; KANWAR, Manu ; NAGEL, Mark R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2021365129A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>PAPALIA, Giuseppe</creatorcontrib><creatorcontrib>BACA, Manuel</creatorcontrib><creatorcontrib>GILMORE, Sarah A</creatorcontrib><creatorcontrib>MUKHERJEE, Prasenjit K</creatorcontrib><creatorcontrib>TAM, Danny W</creatorcontrib><creatorcontrib>JAVANBAKHT, Hassan</creatorcontrib><creatorcontrib>HUNG, Magdeleine S</creatorcontrib><creatorcontrib>KHAN, Shahzada</creatorcontrib><creatorcontrib>THOMAS, Majlinda K</creatorcontrib><creatorcontrib>KANWAR, Manu</creatorcontrib><creatorcontrib>NAGEL, Mark R</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PAPALIA, Giuseppe</au><au>BACA, Manuel</au><au>GILMORE, Sarah A</au><au>MUKHERJEE, Prasenjit K</au><au>TAM, Danny W</au><au>JAVANBAKHT, Hassan</au><au>HUNG, Magdeleine S</au><au>KHAN, Shahzada</au><au>THOMAS, Majlinda K</au><au>KANWAR, Manu</au><au>NAGEL, Mark R</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INTERLEUKIN-2-FC FUSION PROTEINS AND METHODS OF USE</title><date>2023-06-01</date><risdate>2023</risdate><abstract>Provided are serum half-life extended-IL-2 variant (IL-2v) heterodimers having reduced binding to the IL2Rα (CD25) subunit. In particular, Fc-IL-2v heterodimers are provided and methods for making and using, e.g. for enhancing an immune response,</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2021365129A1
source esp@cenet
subjects CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
title INTERLEUKIN-2-FC FUSION PROTEINS AND METHODS OF USE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T05%3A21%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PAPALIA,%20Giuseppe&rft.date=2023-06-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2021365129A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true